PHARMALEX
ActiveSummary
PHARMALEX has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.9m and a net result of €64,882. Equity remains stable across the filed fiscal years (±2.3% per year). Its solvency ranks better than 87% of 1068 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
History
Acts, filings and financial milestones
03-08
State Gazette act
Resignations: MEULEMAN Philippe Charles Louis (director) and BERNARD Guy Ivan Marc (director)Appointment: AMARRIS HOLDING.BE (non-statutory director) · Permanent representative: ROBIN Claude Gilbert André · Reappointment: CDP PETIT & Co SRL (statutory auditor)20 facts ▸
- General meeting, 30-06-2026
- Other statement, première résolution - rapport spécial organe d’administration justification modification objet, sans réserves
- Purpose change
- Statutes amendment
- Other statement, inscription registre public ITAA, personne morale reconnue comme société d’expert-comptable certifié
- Capital
- Other statement, TITRE IV : ADMINISTRATION - CONTROLE, titre statutaire
- Director resignation, MEULEMAN Philippe Charles Louis (director)
- Director resignation, BERNARD Guy Ivan Marc (director)
- Director discharge, MEULEMAN Philippe Charles Louis
- Director discharge, BERNARD Guy Ivan Marc
- Board rule, 1
- +8 further facts in this act
About the unread acts
Of the 5 Belgian State Gazette acts we know for this company, 1 has been read. The other 4 have not been read yet: what they contain is neither established nor disproved here.